The hunt for Covid-19’s origin ramps up — Biden to take a stand on abortion rights — Georgia senators push for Medicaid expansion in infrastructure bill

From: POLITICO Pulse - Thursday May 27,2021 02:07 pm
Presented by PhRMA: Delivered daily by 10 a.m., Pulse examines the latest news in health care politics and policy.
May 27, 2021 View in browser
 
POLITICO's Pulse newsletter logo

By Adam Cancryn and Sarah Owermohle

Presented by

PhRMA

With Rachel Roubein

PROGRAMMING NOTE: Morning Pulse will not publish on Monday, May 31. We'll be back on our normal schedule on Tuesday, June 1.

Editor’s Note: POLITICO Pulse is a free version of POLITICO Pro Health Care's morning newsletter, which is delivered to our s each morning at 6 a.m. The POLITICO Pro platform combines the news you need with tools you can use to take action on the day’s biggest stories. Act on the news with POLITICO Pro.

Quick Fix

— The coronavirus pandemic's origins are now under renewed scrutiny from both the White House and Congress.

— President Joe Biden could use his forthcoming budget request to fulfill a major campaign pledge on abortion rights.

— Georgia's two Democratic senators are urging lawmakers to use Biden’s infrastructure package to expand Medicare in the dozen states that have so far refused to.

WELCOME TO THURSDAY PULSE where some parts of the U.S. are inundated by cicadas, while others are overrun by delicious fruit and don't even know it. Send loquats and tips to acancryn@politico.com and sowermohle@politico.com.

 

A message from PhRMA:

Americans don’t need another barrier to their medicines. We have to lower what patients pay for their medicines. We also have to make sure they are getting the medicines they need. H.R.3 forces a choice between one or the other, but there’s a way to do both. Get the facts at phrma.org/betterway.

 
Driving the Day

THE HUNT FOR COVID-19’s ORIGIN RAMPS UP Amid calls from both congressional Democrats and Republicans for accountability for the pandemic's beginnings, Biden on Wednesday said he ordered the intelligence community to spend the next three months probing the question in hopes of reaching a “definitive conclusion.”

That represents the most transparency yet from the administration about its intelligence efforts as related to Covid. The government is split between two theories of the virus’s origin, Biden said: either the virus naturally jumped to humans from an animal host, or its release was the result of a lab accident in China.

The “lab leak” theory had long been dismissed as unlikely by federal health officials. But it’s received renewed attention in recent weeks, after top scientists urged further investigation and reports that three researchers at the Wuhan Institute of Virology were hospitalized in 2019.

On the Hill, lawmakers from both parties have signaled a willingness to look into the theory themselves, POLITICO’s Andrew Desiderio and Erin Banco report. That could further amp up the pressure on the administration, which has argued any investigation will have a better shot at succeeding if run by an outside multinational entity like the World Health Organization (rather than a government with which China has had strained relations).

In a statement , the Chinese embassy blasted the talk of a lab leak as a “conspiracy theory” and “smear campaign.” Yet as far back as early 2020, Biden had expressed openness to the possibility — along with Republicans, who now say their long-held suspicions have been validated.

On Wednesday night came yet another sign of bipartisan interest: The Senate unanimously passed legislation to require that the Biden administration declassify intelligence related to any possible links between the Wuhan Institute of Virology and the pandemic’s origins.

BIDEN TO TAKE ABORTION RIGHTS STAND The president is expected to leave the Hyde amendment and other anti-abortion provisions out of his forthcoming budget blueprint, his first attempt as president to confront this divisive issue, POLITICO’s Alice Miranda Ollstein reports.

Biden’s omission of the Hyde amendment — the longtime provision banning nearly all federal abortion funding — would be largely symbolic, given Democrats’ narrow margins in Congress. But it sends a clear message at a time when states are trying to limit abortion access and the Supreme Court plans to hear a direct challenge to Roe v. Wade.

Biden first vowed to do away with the Hyde amendment as a candidate, saying in 2019 that there was “no rationale” for withholding federal funding to care for those covered by federal programs.

While many Democrats have long opposed the prohibition, appropriators last year opted not to fight its inclusion, for fear of the political cost of a repeal that would, regardless of their votes, ultimately be blocked by then-President Donald Trump.

Any effort to do away with Hyde this year is likely to fail as well ; even some moderate Democrats in the Senate are still in favor of keeping the ban in effect.

Still, abortion rights advocates are pressing Biden and Democratic lawmakers to make an effort anyway. Ensuring that poor people, disproportionately affected by cuts to abortion access, can still recieve the procedure is a matter of racial and economic justice, they say.

Republicans and anti-abortion organizations are keeping close eye on Biden’s budget, too, highlighting in particular his past support for Hyde during his decades as a senator.

GEORGIA SENATORS: FEDERALIZE MEDICAID EXPANSION Democratic Sens. Raphael Warnock and Jon Ossoff penned a letter to Senate leaders Wednesday, pressing them to “to close the coverage gap in Medicaid non-expansion states through federal action,” POLITICO’s Rachel Roubein reports.

The coronavirus relief bill Biden signed in March offered new incentives for holdout states to expand their programs, but so far none have taken advantage of them. The White House and Democratic lawmakers have since weighed using their infrastructure package as a vehicle for covering the 2.2 million people in holdout states who lack coverage.

Warnock and Ossoff stopped short of endorsing a specific policy. But the two wrote in their letter that they’re working on a legislative fix. The letter also noted that CMS could potentially fix the coverage gap by creating its own federal workaround.

 

SUBSCRIBE TO "THE RECAST" TODAY: Power is shifting in Washington and in communities across the country. More people are demanding a seat at the table, insisting that politics is personal and not all policy is equitable. The Recast is a twice-weekly newsletter that explores the changing power dynamics in Washington and breaks down how race and identity are recasting politics and policy in America. Get fresh insights, scoops and dispatches on this crucial intersection from across the country and hear critical new voices that challenge business as usual. Don't miss out, SUBSCRIBE . Thank you to our sponsor, Intel.

 
 
Coronavirus

BELGIUM LIMITS USE OF J&J VACCINE Johnson & Johnson’s single-shot Covid vaccine took another hit on Wednesday when Belgium decided it would no longer give that shot to women aged 41 years or younger , POLITICO Europe’s Helen Collis reports.

Belgian authorities made the change after a woman died from a rare clotting problem previously linked to the J&J vaccine. Belgium has asked the European Medicines Agency to investigate that potential link, and in the meantime will limit access to the shot.

FDA AUTHORIZES COVID TREATMENT The agency on Wednesday authorized a monoclonal antibody treatment for emergency use in some vulnerable Covid patients, two months after trial data showed its efficacy, POLITICO’s Lauren Gardner reports.

The treatment, developed by GlaxoSmithKline and Vir Biotechnology, is intended for use in older adults or those with underlying conditions that put them at higher risk of severe infection. Interim data from a late-stage trial has suggested it can reduce hospitalization or death in those kinds of patients by 85 percent.

 

Advertisement Image

 
Inside the Humphrey Building

CMS PROPOSES DELAYING VALUE-BASED DRUG MEASURES The agency wants to press pause on several provisions of a Trump-era drug rule meant to let states and manufactures pay for Medicaid drugs based on their effectiveness, Rachel writes.

Drugmakers were originally required to report multiple best prices charged for a drug in a value-based purchasing arrangement beginning in January 2022. But CMS is proposing a six-month delay to that deadline. It also wants to delay by two years plans to include U.S. territories in the Medicaid drug rebate program.

FIRST IN PULSE: AFFORDABLE DRUG BILL REVIVED Sen. Tina Smith (D-Minn.) this morning plans to introduce a bill to let Medicare negotiate drug prices, a long-sought Democratic priority that has been left out of the upcoming infrastructure package.

The details: The Affordable Medications Act — backed by a range of original cosponsors, including drug pricing hardliners Sens. Bernie Sanders (I-Vt.) and Elizabeth Warren (D-Mass.) — would also encourage generic competition and boost incentives for developing new antibiotics.

Smith on Wednesday also introduced a bill with Sen. Debbie Stabenow (D-Mich.) to increase mental health coverage for low-income families and people with disabilities.

SENATE BILL WOULD HELP RECRUIT RURAL DOCTORS Bipartisan legislation set to be reintroduced today would extend a program allowing doctors to stay in the U.S. after completing their residencies, as long as they practice in areas suffering from physician shortages.

The bill, led by Sens. Amy Klobuchar (D-Minn.), Susan Collins (R-Maine), Jacky Rosen (D-Nev.) and Joni Ernst (R-Iowa) also proposes expanding the number of doctors who can participate in the program, and would also allow the physicians’ spouses to work, as well.

 

SUBSCRIBE TO WEST WING PLAYBOOK: Add West Wing Playbook to keep up with the power players, latest policy developments and intriguing whispers percolating inside the West Wing and across the highest levels of the Cabinet. For buzzy nuggets and details you won't find anywhere else, subscribe today.

 
 
Names in the News

Kasey Hampton is joining Families USA. Hampton will be the organization’s senior manager of storytelling and engagement communications. She was previously the press secretary for Sen. Tammy Baldwin (D-Wis.).

HHS appoints Anjali Forber-Pratt to its Administration for Community Living. Forber-Pratt is the new director of the National Institute on Disability, Independent Living and Rehabilitation Research, and previously was an assistant professor at Vanderbilt University.

 

A message from PhRMA:

Americans don’t need yet another barrier to their medicines. Especially now. Now is the time for us to rethink how we get the medicines we need. But there are right ways and wrong ways. While it may sound good on paper, H.R.3 would threaten patients’ access to treatments, put nearly a million American jobs at risk and jeopardize current and future medical innovation – all while failing to address the broader challenges facing America’s health care system.

We have to lower what patients pay for their medicines. We also have to make sure patients are getting the medicines they need. There’s a way to do both, but H.R.3 isn’t it. Get the facts at phrma.org/betterway.

 
What We're Reading

New York’s Mount Sinai Health System will open a laboratory that can process 100,000 tests a day in hopes of serving the city’s public schools, The New York Times’ Emily Anthes reports.

Global vaccination program COVAX is falling well short of its goal of quickly inoculating the world, stymied by countries hoarding shots, The Wall street Journal’s Gabriele Steinhauser, Drew Hinshaw and Betsy McKay report.

The first winner of Ohio’s $1 million vaccine lottery is engineer and recent college graduate Abbigail Bugenske, The Washington Post’s Reis Thebault writes.

 

Follow us on Twitter

Joanne Kenen @joannekenen

Adriel Bettelheim @abettel

Jason Millman @jasonmillman

Lauren Morello @lmorello_dc

Sara Smith @sarasmarley

Adam Cancryn @adamcancryn

Tucker Doherty @tucker_doherty

Dan Goldberg @dancgoldberg

David Lim @davidalim

Susannah Luthi @SusannahLuthi

Alice Miranda Ollstein @aliceollstein

Sarah Owermohle @owermohle

Carmen Paun @carmenpaun

Rachel Roubein @rachel_roubein

Darius Tahir @dariustahir

Erin Banco @ErinBanco

Lauren Gardner @Gardner_LM

Katherine Ellen Foley @katherineefoley

 

Follow us

Follow us on Facebook Follow us on Twitter Follow us on Instagram Listen on Apple Podcast
 

To change your alert settings, please log in at https://www.politico.com/_login?base=https%3A%2F%2Fwww.politico.com/settings

This email was sent to by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

Please click here and follow the steps to .

More emails from POLITICO Pulse